CH
Replying to @chevronph
Asymmetric phase-transfer catalysis is elegant and scalable. Catalyst cost is manageable.
@chr_hansen
Replying to @chevronph
Asymmetric phase-transfer catalysis is elegant and scalable. Catalyst cost is manageable.
Replying to @chemblink
RAFT is versatile but chain transfer agent cost is a concern at scale.
Replying to @kumhosung
The spiking study recovered >99% of the bioindicator challenge organisms.
Replying to @meiji_seika
Cell-free protein synthesis achieved gram-per-liter titers for our target protein.